The FDA approved Astellas’s Vyloy as a treatment for advanced cases of gastric or gastroesophageal junction (GEJ) adenocarcinoma positive for a protein called claudin 18.2. It’s the first FDA-approved therapy for this target. The post Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer appeared first on MedCity News.
Within a matter of months, we’re likely to see substantial growth in the number of EP ablation procedures performed in surgery centers outside the hospital. Here’s what we can expect. The post How the Move of Ablation Procedures into Surgery Centers Will Transform Electrophysiology appeared first on MedCity News.
Closing cancer health equity gaps requires medical breakthroughs made possible by new funding approaches. The post The Funding Model for Cancer Innovation is Broken — We Can Fix It appeared first on MedCity News.
Kaiser Permanente is showing no signs of slowing down when it comes to its Risant Health experiment. The organization is currently on the prowl for more acquisition targets, Kaiser CEO Greg Adams said at HLTH. The post Why Greg Adams Believes Risant Health Will Be Successful In Its Mission to Scale VBC Across the Country…
Research shows that medical residents of all specialties are avoiding states that ban abortion. This was discussed during a panel discussion at Engage at HLTH on Sunday in Las Vegas. The post How the Dobbs Decision Impacts Medical Practice Beyond Just OBGYNs appeared first on MedCity News.
Pharmaceutical and biotech companies are using generative AI to predict drug-target interactions, optimize lead compounds, and generate novel molecular structures. During the recent MedCity News INVEST Digital Health conference, a panel discussed these applications and more. The post How Generative AI Will Find a Place in the Pharma Industry Now and in the Years to…
On the surface, it sounds positively delightful – who wouldn’t want to help dear grandma avoid the nursing home? But as is often the case with these sweeping government proposals, the devil is in the details. The post Why Harris’ Medicare at Home Plan is Good but Flawed appeared first on MedCity News.
Investing in reproductive health is not only a strategic financial move but also a moral imperative. By channeling our investment dollars into the critical areas described above, we can support innovative solutions, expand access to essential services, and uphold the fundamental rights of women across the nation. The post Investing in Reproductive Health Companies Post-Dobbs:…
Waymark’s community-based interventions reduce hospital and emergency department visits and improve care quality, according to a new study. The company supports Medicaid patients by connecting them with community health workers, therapists, pharmacists and care coordinators in their area. The post New Study Shows That Waymark Reduces ED, Hospital Visits for Medicaid Patients appeared first on…
New research shows that there are more than 14,000 unique IP addresses across the globe exposing patients’ potentially sensitive medical information on the public internet. Nearly half of these exposures are in the U.S. The post Nearly 7,000 US Healthcare Devices & Records Are Exposed to the Public Internet, Research Shows appeared first on MedCity…